| NRBO Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||
Below is a table of the NRBO shares outstanding history going back to 12/31/2019:
Also see: NRBO Market Cap History NRBO YTD Return |
NRBO Shares Outstanding History — NeuroBo Pharmaceuticals Share Count Over Time
As of 11/4/2024 NeuroBo Pharmaceuticals has 8.62 million NRBO shares outstanding. Investors often track the NRBO shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows NRBO share count trends over time, with 19 historical shares outstanding datapoints presented, dating back to 12/31/2019.
| NRBO Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||
NRBO Historical Shares Outstanding: +437.29% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||
| NRBO Stock Price Chart |
| About MetaVia Inc |
| NeuroBo Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on transforming cardiometabolic diseases. It is developing DA-1241 for the treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Type 2 Diabetes Mellitus (T2DM), and is developing DA-1726 for the treatment of obesity. DA-1241 is a novel G-Protein-Coupled Receptor 119 (GPR119) agonist with development optionality as a standalone and/or combination therapy for both MASH and T2DM. Agonism of GPR119 in the gut promotes the release of key gut peptides, glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide, and peptide YY. We show 19 historical shares outstanding datapoints in our coverage of NRBO's shares outstanding history. Understanding the changing numbers of NRBO shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like NRBO versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching NRBO by allowing them to research NRBO shares outstanding history as well as any other stock in our coverage universe. |
| NRBO Current Stock Quote |
Quotes delayed 20 minutes  Free NRBO Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| NRBO Share Performance |
| Shares Outstanding Peers |
| NeuroBo Pharmaceuticals (NRBO) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
NRC Shares Outstanding History NRIX Shares Outstanding History NRXP Shares Outstanding History NSPR Shares Outstanding History NSTG Shares Outstanding History NTEC Shares Outstanding History NTGN Shares Outstanding History NTHI Shares Outstanding History NTLA Shares Outstanding History NTRA Shares Outstanding History More Healthcare companies » |
NRBO Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
